target

SKYEPHARMA

bidder

Vectura Group

£407m

14 dealmakers

target

Corin Group

bidder

Investor Consortium

£35m

5 dealmakers

target

Envision Pharma

bidder

ARDIAN

value n/a

4 dealmakers

target

Idis Group Holdings

bidder

Clinigen Group

value n/a

2 dealmakers

target

Db Ashbourne

bidder

ETHYPHARM

value n/a

4 dealmakers

target

Amdipharm Mercury

bidder

Advanz Pharma Corp

£2,300m

25 dealmakers

target

Sinclair Is Pharma's Non-aesthetics Business

bidder

Alliance Pharma Lc

value n/a

4 dealmakers

target

Concept Life Sciences

bidder

Spectris

£163m

13 dealmakers

target

Eusa Pharma (critical Care Business)

bidder

Serb Pharmaceuticals (belgium)

value n/a

2 dealmakers

target

Sinclair Pharma

bidder

Huadong Medicine Co

£179m

27 dealmakers

target

Btg

bidder

Boston Scientific Corporation

£3,029m

64 dealmakers

target

PELLEPHARM

bidder

Leo Pharma

£591m

8 dealmakers

target

Nestle Skin Health

bidder

Eqt Partners

£7,808m

196 dealmakers

target

Trimb Holding

bidder

Karo Pharma

£275m

54 dealmakers

target

Synpromics

bidder

ASKBIO

value n/a

4 dealmakers

target

Bioclinica (clinical Research Site Business)

bidder

Pharmaceutical Product Development

value n/a

24 dealmakers

target

Takeda Pharmaceutical Company (drug Portfolio)

bidder

Acino International

£159m

24 dealmakers

target

Riemser

bidder

ESTEVE

value n/a

54 dealmakers

target

Covis Pharma

bidder

Apollo Global Management

value n/a

91 dealmakers

target

Huntsworth

bidder

Clayton Dubilier & Rice

£524m

63 dealmakers

target

SYMPHOGEN

bidder

Servier International

value n/a

30 dealmakers

target

Cello Health

bidder

Arsenal Capital Partners

£181m

31 dealmakers

target

Envision Pharma

bidder

Gho Capital Partners

value n/a

36 dealmakers

target

Boston Scientific Corporation (btg Specialty Pharmaceuticals Business)

bidder

Charterhouse Capital Partners

£599m

43 dealmakers

target

Clario (ert)

bidder

Cinven

value n/a

97 dealmakers

target

Cytel

bidder

Astorg Partners

value n/a

27 dealmakers

target

Lucid Group

bidder

Intermediate Capital Group (icg)

value n/a

29 dealmakers

target

NUTRAQ

bidder

Orkla Asa

£262m

11 dealmakers

target

Udg Healthcare

bidder

Clayton Dubilier & Rice

£2,777m

110 dealmakers

target

SYMERES

bidder

Keensight Capital

value n/a

53 dealmakers

target

Vectura Group

bidder

Philip Morris International

£1,025m

97 dealmakers

target

Hra Pharma

bidder

Perrigo Company

£1,515m

54 dealmakers

target

Acino International

bidder

Abu Dhabi Development Corporation (adq)

value n/a

7 dealmakers

target

BIOAGILYTIX

bidder

Cinven

value n/a

72 dealmakers

target

Eusa Pharma

bidder

Recordati

£638m

39 dealmakers

target

Clario (drug Safety Solutions Unit)

bidder

Stanley Capital Partners

value n/a

19 dealmakers

target

Norgine

bidder

Goldman Sachs Asset Management

£1,533m

80 dealmakers

target

Open Health

bidder

Astorg Partners

£790m

25 dealmakers

target

UMOTIF

bidder

Athyrium Capital Management

£20m

6 dealmakers

target

Avania

bidder

Astorg Partners

value n/a

30 dealmakers

target

Emmes Corporation

bidder

New Mountain Capital

£653m

72 dealmakers

target

Laboratoire X.o

bidder

Stanley Capital Partners

value n/a

9 dealmakers

target

The Binding Site Group

bidder

Thermo Fisher Scientific

£2,250m

47 dealmakers

target

INKE

bidder

Keensight Capital

£211m

20 dealmakers

target

DINAMIQS

bidder

Siegfried Holding

value n/a

15 dealmakers

target

INSTEM

bidder

Archimed

£203m

43 dealmakers

target

Ergomed

bidder

Permira Advisers

£703m

45 dealmakers

target

Alcresta Therapeutics

bidder

Linden Capital Partners

value n/a

12 dealmakers

target

Renaissance Pharma

bidder

Essential Pharma

value n/a

5 dealmakers